Related Experiment Video
Updated: May 31, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care
David S Y Ong1, Irene P Jongerden, Anton G Buiting
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. d.s.y.ong@umcutrecht.nl
Objectives:
We quantified the association between antibiotic exposure and acquisition of antibiotic resistance in Pseudomonas aeruginosa and Enterobacter species in intensive care unit patients.
Design:
Prospective cohort study.
Setting And Patients:
In 1,201 patients, respiratory tract colonization was determined through regular screening on admission, twice weekly, and on discharge. Primary outcome was the acquisition of antibiotic resistance in previous antibiotic sensitive P. aeruginosa and Enterobacter species, with acquisition attributable to cross-transmission excluded based on genotyping and epidemiologic linkage. Cox regression analysis, adjusted for covariates, was performed to calculate hazard ratios of patients exposed to antibiotics compared to patients not exposed to antibiotics.
Measurements And Main Results:
In total, 194 and 171 patients were colonized with P. aeruginosa and Enterobacter species, respectively. Two or more cultures per episode were available for 126 and 108 patients. For P. aeruginosa, ceftazidime exposure was associated with 6.3 acquired antibiotic resistance events per 100 days of exposure, whereas incidence rates were lower for ciprofloxacin, meropenem, and piperacillin-tazobactam. In multivariate analysis, meropenem, ciprofloxacin, and ceftazidime were significantly associated with risk of resistance development in P. aeruginosa (adjusted hazard ratio, 11.1; 95% confidence interval, 2.4-51.5 for meropenem; adjusted hazard ratio, 4.1; 95% confidence interval, 1.1-16.2 for ciprofloxacin; adjusted hazard ratio, 2.5; 95% confidence interval, 1.1-5.5 for ceftazidime). For Enterobacter, ceftriaxone and ciprofloxacin exposure were associated with most antibiotic resistance acquisitions. No significant associations were found in multivariate analysis.
Conclusions:
Meropenem exposure is associated with the highest risk of resistance development in P. aeruginosa. Increasing carbapenem use attributable to emergence of Gram-negative bacteria producing extended-spectrum β-lactamases will enhance antibiotic resistance in P. aeruginosa.
Insights
Antibiotic exposure, particularly meropenem, significantly increases the risk of antibiotic resistance development in Pseudomonas aeruginosa in intensive care units. This highlights the need to monitor antibiotic use and resistance trends.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pharmacology
Background:
- Antibiotic resistance is a growing global health threat, particularly in intensive care units (ICUs).
- Pseudomonas aeruginosa and Enterobacter species are common ICU pathogens known for developing resistance.
- Understanding the link between specific antibiotic exposures and resistance acquisition is crucial for antimicrobial stewardship.
Purpose of the Study:
- To quantify the association between antibiotic exposure and the acquisition of antibiotic resistance in Pseudomonas aeruginosa and Enterobacter species.
- To identify specific antibiotics that contribute to resistance development in ICU patients.
Main Methods:
- A prospective cohort study involving 1,201 ICU patients.
- Regular respiratory tract screening for P. aeruginosa and Enterobacter colonization.
- Cox regression analysis to calculate hazard ratios for antibiotic resistance acquisition based on antibiotic exposure.
- Genotyping and epidemiologic linkage were used to exclude cross-transmission.
Main Results:
- Meropenem, ciprofloxacin, and ceftazidime were significantly associated with increased risk of resistance development in P. aeruginosa.
- Meropenem exposure showed the highest adjusted hazard ratio (11.1) for P. aeruginosa resistance.
- Ceftriaxone and ciprofloxacin exposure were linked to most antibiotic resistance acquisitions in Enterobacter species, though not significant in multivariate analysis.
Conclusions:
- Meropenem exposure is strongly associated with the highest risk of resistance development in P. aeruginosa.
- Increased carbapenem use may exacerbate antibiotic resistance in P. aeruginosa, especially with the rise of Gram-negative bacteria producing extended-spectrum beta-lactamases.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia I: Introduction

